AI Glasses to Help Dementia Patients Live Independently – Launching Soon

The prospect of maintaining independence is central to quality of life, and for individuals living with dementia, that can become increasingly challenging. Now, a new technology – smart glasses powered by artificial intelligence – offers a potential lifeline. Developed by CrossSense Ltd, and known as CrossSense, this technology aims to provide real-time assistance and guidance to people with dementia, helping them navigate daily life with greater confidence and autonomy.

The technology recently received a significant boost, winning a £1 billion prize – the Longitude Prize for Dementia – awarded by Challenge Works and supported by Nesta, Alzheimer’s Society and Innovate UK. This funding will be instrumental in bringing the technology to market, with a smartphone version expected later this year and the smart glasses themselves slated for release in early 2027.

How CrossSense Works: A Virtual Companion

At the heart of CrossSense is an AI-powered virtual assistant named Wispy. Integrated into smart glasses equipped with a camera, microphone, and speakers, Wispy provides a multi-sensory support system. The glasses aren’t just a visual aid; they actively engage with the user through verbal cues and text displayed directly in their field of vision. This can include providing directions, offering feedback during activities, posing questions to stimulate cognitive function, initiating simple conversations, and prompting memory recall.

Szczepan Orlins, CEO of CrossSense Ltd, explained that the prize money will directly facilitate the product launch. The company is collaborating with various hardware manufacturers to integrate the CrossSense software into different frame designs, ensuring compatibility with prescription lenses and hearing aids. This approach allows for personalization and caters to individual needs.

Beyond Assistance: Adapting to Individual Needs

The system’s adaptability is a key feature. Users, or their caregivers, can input information about the level of support required into an associated application. Wispy then utilizes machine learning to tailor its assistance to the individual’s specific needs, even accounting for changes in their condition over time. This personalized approach is crucial, as dementia manifests differently in each person.

Early testing, as reported by A1.ro, has shown promising results. A study conducted by Professor Julia Simner at the University of Sussex, involving 23 pairs of individuals with dementia and their caregivers, demonstrated a significant improvement in object recognition. Participants correctly identified 46% of household objects without the glasses, but that number jumped to 82% while wearing them. Remarkably, even an hour after removing the glasses, recognition rates remained elevated at 78%.

The Growing Need for Dementia Support

The development of CrossSense comes at a critical time. Dementia is a growing global health concern, with an estimated 150 million people expected to be living with the condition by 2050. In Romania, statistics indicate a concerning trend, with over 300,000 people currently affected, according to The Poc. This increasing prevalence places a significant burden on healthcare systems, families, and caregivers.

The challenges of caring for someone with dementia are multifaceted, requiring a combination of medical knowledge, empathy, and unwavering patience. As The Poc details, effective care involves understanding the different types of dementia – including Alzheimer’s disease, Lewy body dementia, vascular dementia, and frontotemporal dementia – and adapting strategies to address the specific behavioral and communication difficulties that may arise.

Cost and Availability

While the technology holds considerable promise, accessibility remains a key consideration. CrossSense is projected to be available through a subscription model, costing approximately £50 per month. The smart glasses themselves are estimated to cost up to £1,000, though prices may decrease over time. Initially, the technology will be marketed directly to consumers in the United Kingdom, with plans for expansion into other countries in the future.

Expert Perspectives and Future Research

Foyzul Rahman, an expert in cognitive decline at Loughborough University, highlights the innovative aspect of CrossSense: its ability to provide real-time guidance. Though, he likewise emphasizes the need for larger, more rigorously controlled studies to confirm the technology’s real-world benefits.

Rahman also raises important ethical considerations, particularly regarding data privacy and informed consent, given that the technology collects data from users. These are valid points, and ongoing dialogue about responsible implementation will be essential as the technology becomes more widely available.

Further research will also focus on the potential of addressing vision problems associated with dementia. As DC Medical reports, improving visual function through interventions like cataract surgery or corrective lenses may even support reduce the risk of developing dementia in older adults.

The development of CrossSense represents a significant step forward in the quest to support individuals living with dementia and empower them to maintain their independence. While further research and careful consideration of ethical implications are necessary, this technology offers a hopeful glimpse into a future where AI can play a vital role in enhancing the quality of life for those affected by this challenging condition. The next phase involves a pilot project in late 2026, gathering real-world data to refine the technology before its broader release.